Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest CyVek Inc. Stories

2014-04-04 08:24:56

MINNEAPOLIS, April 4, 2014 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH), d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met. CyVek has developed a transformative immunoassay technology, CyPlex(TM), which integrates an innovatively designed microfluidic cartridge with a state-of-the-art analyzer to deliver the most advanced and efficient bench top...

2013-10-16 08:29:02

WALLINGFORD, Conn., Oct. 16, 2013 /PRNewswire/ -- CyVek, Inc., an innovator in multi-analyte immunoassay technology, announced today that it has appointed Bill Dubiel to the role of Chief Commercial Officer. In this role, Mr. Dubiel will lead CyVek's global commercialization efforts for the new CyPlex(TM) System. Mr. Dubiel will report to CyVek's President and CEO, Per Hellsund. Per Hellsund, CyVek founder, President and CEO commented, "We are very pleased to have Bill join our...

2013-02-04 08:25:48

WALLINGFORD, Conn., Feb. 4, 2013 /PRNewswire/ -- CyVek, Inc., an innovator in multi-analyte immunoassay technology, announced today that it has secured a Series D round of financing in the amount of $5.5 million. Connecticut Innovations and a group of private investors participated in the round. The Series D funding enables the company to create the infrastructure needed to commercialize its novel immunoassay technology, CyPlex(TM), an integrated test system which includes a proprietary...